Regeneron Pharmaceuticals | REGN - Market Capitalization

Stock Price
787.04
Daily Change
7.37 0.95%
Monthly
3.20%
Yearly
10.35%
Q1 Forecast
755.50

Regeneron Pharmaceuticals reported $86B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Agenus USD 204M 164M Jun/2025
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
Astellas Pharma JPY 4.33T 546.23B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 12.21B 1.81B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Kyowa Hakko Kirin JPY 1.36T 28.23B Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pfizer USD 152.89B 11.32B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 118.94B 1.6B Feb/2026
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026